Medication Adherence Changes in Blacks with Diabetes: A Mixed Methods Study
Deepika Rao1, Martha Maurer2, Jodi Meyer3
1Social and Administrative Sciences, School of Pharmacy, University of Wisconsin-Madison.
American Journal of Health Behavior
|February 6, 2020
Summary
Improving medication adherence in Black adults with type 2 diabetes mellitus (T2DM) requires addressing specific beliefs and tailoring interventions. Psychosocial factors like self-efficacy and depressive symptoms significantly impact adherence over time.
Area of Science:
- Medical Research
- Public Health
- Behavioral Science
Background:
- Type 2 diabetes mellitus (T2DM) management requires consistent medication adherence.
- Understanding factors influencing medication adherence among Black adults with T2DM is crucial for effective treatment.
Purpose of the Study:
- To longitudinally evaluate changes in medication adherence among Black adults with T2DM.
- To identify psychosocial and interpersonal factors influencing these adherence changes.
- To determine barriers and facilitators of T2DM medication adherence in this population.
Main Methods:
- Explanatory sequential mixed methods design with 287 Black adult patients with T2DM in Wisconsin.
- Quantitative surveys assessed medication adherence, psychosocial, and interpersonal factors over time.
- Qualitative semi-structured interviews explored participants' perceptions of adherence changes.
Main Results:
- Increased adherence correlated with lower medicine concerns, higher self-efficacy, fewer depressive symptoms, and less negative illness perceptions.
- Patient perceptions highlighted adherence motivators, social support, and complex medication regimens.
- Barriers and facilitators were present in individuals with both increased and decreased adherence.
Conclusions:
- Addressing specific beliefs of Black individuals regarding T2DM medications is essential for improving adherence.
- Interventions should be tailored, incorporating interpersonal factors to enhance medication adherence.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
791
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
791
01:28Drug Therapy
205
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
205
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
190
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
190
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
01:21Drug Dosing: Obese Patients
167
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
167
01:15Drug Dosing: Geriatric Patients
175
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
175